|
[1]
|
Bray, F., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Barta, J.A., Powell, C.A. and Wisnivesky, J.P. (2019) Global Epidemiol-ogy of Lung Cancer. Annals of Global Health, 85, 8. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lardinois, D., et al. (2006) ESTS Guidelines for Intraoperative Lymph Node Staging in Non-Small Cell Lung Cancer. European Journal of Cardio-Thoracic Surgery, 30, 787-792. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Darling, G.E., et al. (2011) Randomized Trial of Mediastinal Lymph Node Sampling versus Complete Lymphadenectomy during Pulmonary Resec-tion in the Patient with N0 or N1 (Less than Hilar) Non-Small Cell Carcinoma: Results of the American College of Sur-gery Oncology Group Z0030 Trial. The Journal of Thoracic and Cardiovascular Surgery, 141, 662-670. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
David, E.A., et al. (2017) Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? The Annals of Thoracic Surgery, 103, 226-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Mountain, C.F. (1997) Revisions in the International System for Staging Lung Cancer. Chest, 111, 1710-1717. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Adachi, H., et al. (2017) Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study. Journal of Tho-racic Oncology, 12, 85-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Dezube, A.R., et al. (2020) Analysis of Lymph Node Sampling Minimums in Early Stage Non-Small-Cell Lung Cancer. Seminars in Thoracic and Cardiovascular Surgery. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wankhede, D. (2021) Evaluation of Eighth AJCC TNM Sage for Lung Cancer NSCLC: A Meta-Analysis. Annals of Surgical Oncology, 28, 142-147. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Zhang, Y., et al. (2020) Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer. The Annals of Thoracic Surgery, 109, 1061-1068. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hughes, M.J., Chowdhry, M.F., Woolley, S.M. and Walker, W.S. (2011) In Patients Undergoing Lung Resection for Non-Small Cell Lung Cancer, Is Lymph Node Dissection or Sampling Superior? Interactive CardioVascular and Thoracic Surgery, 13, 311-315. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Maniwa, T., et al. (2013) Recurrence of Mediastinal Node Cancer after Lobe-Specific Systematic Nodal Dissection for Non-Small-Cell Lung Cancer. European Journal of Car-dio-Thoracic Surgery, 44, e59-e64. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yoon, H.Y., et al. (2018) Prognosis of Multi-Level N2-Positive Non-Small Cell Lung Cancer According to Lymph Node Staging Using Endobronchial Ultrasound-Transbronchial Bi-opsy. Thoracic Cancer, 9, 684-692. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Aokage, K., et al. (2010) Subcarinal Lymph Node in Upper Lobe Non-Small Cell Lung Cancer Patients: Is Selective Lymph Node Dissection Valid? Lung Cancer, 70, 163-167. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Deng, H.Y., et al. (2020) Lobe-Specific Lymph Node Dissec-tion for Clinical Early-Stage (cIA) Peripheral Non-Small Cell Lung Cancer Patients: What and How? Annals of Surgical Oncology, 27, 472-480. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wu, Y., et al. (2020) Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-Small Cell Lung Cancer (T1b). Frontiers in Surgery, 7, Article ID: 580203. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Okada, M., et al. (1998) Proposal for Reasonable Mediastinal Lymphadenectomy in Bronchogenic Carcinomas: Role of Subcarinal Modes in Selective Dissection. The Journal of Thoracic and Cardiovascular Surgery, 949-953. [Google Scholar] [CrossRef]
|
|
[18]
|
Tsitsias, T., et al. (2021) New N1/N2 Classification and Lobe Specific Lymphatic Drainage: Impact on Survival in Patients with Non-Small Cell Lung Cancer Treated with Sur-gery. Lung Cancer, 151, 84-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Haruki, T., et al. (2015) Mediastinal Nodal Involvement in Pa-tients with Clinical Stage I Non-Small-Cell Lung Cancer: Possibility of Rational Lymph Node Dissection. Journal of Thoracic Oncology, 10, 930-936. [Google Scholar] [CrossRef]
|
|
[20]
|
Cao, J., et al. (2018) Prognostic Impact of Lymphadenecto-my on Outcomes of Sublobar Resection for Stage IA Non-Small Cell Lung Cancer = 2 cm. The Journal of Thoracic and Cardiovascular Surgery, 156, 796-805e4. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
杨耀湘. 非小细胞肺癌患者ALK、EGFR、KRAS基因的检测及临床病理特征[J]. 中国现代药物应用, 2018, 12(8): 219-220.
|
|
[22]
|
Hishida, T., et al. (2018) A Randomized Phase III Trial of Lobe-Specific vs. Systematic Nodal Dissection for Clinical Stage I-II Non-Small Cell Lung Cancer (JCOG1413). Japanese Journal of Clinical Oncology, 48, 190-194. [Google Scholar] [CrossRef] [PubMed]
|